A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Hummingbird Bioscience
Hummingbird Bioscience
Maia Biotechnology
AVEO Pharmaceuticals, Inc.
KaliVir Immunotherapeutics
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Merck Sharp & Dohme LLC
Eli Lilly and Company
AstraZeneca
Merck Sharp & Dohme LLC
McGuire Institute
Neonc Technologies, Inc.
Merck Sharp & Dohme LLC
VLP Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Maia Biotechnology
Incyte Corporation
Inhibrx Biosciences, Inc
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
TScan Therapeutics, Inc.
Incyte Corporation
ImmVira Pharma Co. Ltd
AVM Biotechnology Inc
Hookipa Biotech GmbH
3B Pharmaceuticals GmbH
Bicara Therapeutics
QBiotics Group Limited
Leap Therapeutics, Inc.
Leap Therapeutics, Inc.
CMR Surgical Ltd
Rakuten Medical, Inc.
Numab Therapeutics AG
Galderma R&D
Revolution Medicines, Inc.
Regeneron Pharmaceuticals
Creative Biosciences (Guangzhou) Co., Ltd.
LEO Pharma
Intensity Therapeutics, Inc.
Alpha Tau Medical LTD.
Replimune Inc.
Momentum Data
Carisma Therapeutics Inc
DermaSensor, Inc.
Alpha Tau Medical LTD.
EpicentRx, Inc.